Nanoscale Melittin@Zeolitic Imidazolate Frameworks for Enhanced Anticancer Activity and Mechanism Analysis
Related Experiment Video
Updated: Feb 8, 2026

Watershed Planning within a Quantitative Scenario Analysis Framework
Published on: July 24, 2016
Yawei Li1,2, Na Xu1,2, Wenhe Zhu1,2
1Key Laboratory of Jilin Province for Zoonosis Prevention and Control , Institute of Military Veterinary Medicine, Academy of Military Medical Sciences , Changchun , 130122 , P. R. China.
Abstract:
The cytolytic peptide melittin (MLT) is an important candidate of anticancer drug owing to its hemolytic properties. Nevertheless, its clinical applications are severely restricted as a result of its nonspecific toxicities like hemolysis. In this work, we reported MLT-loaded zeolitic imidazolate framework-8 (MLT@ZIF-8) nanoparticles (NPs). The formed MLT@ZIF-8 NPs not only possess excellent stability but also efficiently inhibit the hemolysis bioactivity of MLT. Confocal scanning imaging and cytotoxicity experiments revealed that as-synthesized MLT@ZIF-8 NPs exhibit enhanced cellular uptake and cytotoxicity toward cancer cells compared to MLT. The mechanism is well investigated by a series of transcriptome analysis, which indicates that MLT@ZIF-8 NPs can regulate the expression of 3383 genes, and the PI3K/Akt-regulated p53 pathway is involved in MLT@ZIF-8 NPs induced A549 cells apoptosis. Finally, MLT@ZIF-8 NPs exhibit enhanced antitumor activity than free MLT in vivo, while no obvious systemic toxicity has been found. This work emphasizes the great potential of utilizing MOF as a simple and efficient nanoplatform for deliverying cytolytic peptides in cancer treatment, and also the investigation on the antitumor mechanism could provide theoretical support for clinical usage of MLT.
Insights
Melittin-loaded zeolitic imidazolate framework-8 nanoparticles (MLT@ZIF-8 NPs) show enhanced cancer cell killing and reduced toxicity. This novel approach improves melittin
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapeutics
Background:
- Melittin (MLT) is a cytolytic peptide with anticancer potential but limited by nonspecific toxicity, such as hemolysis.
- Zeolitic imidazolate framework-8 (ZIF-8) is a metal-organic framework (MOF) with tunable properties for drug delivery.
Purpose of the Study:
- To develop a novel nanoplatform for melittin delivery to enhance its anticancer efficacy and reduce toxicity.
- To investigate the mechanism of action of melittin-loaded ZIF-8 nanoparticles (MLT@ZIF-8 NPs) in cancer treatment.
Main Methods:
- Synthesis and characterization of MLT@ZIF-8 nanoparticles.
- In vitro cytotoxicity assays and confocal scanning imaging for cellular uptake.
- Transcriptome analysis to elucidate the molecular mechanism of action.
- In vivo antitumor activity and systemic toxicity evaluation.
Main Results:
- MLT@ZIF-8 NPs demonstrated enhanced stability and inhibited melittin's hemolytic activity.
- The nanoparticles exhibited increased cellular uptake and cytotoxicity against cancer cells compared to free melittin.
- Transcriptome analysis revealed regulation of 3383 genes, implicating the PI3K/Akt-regulated p53 pathway in cancer cell apoptosis.
- In vivo studies showed improved antitumor activity with no significant systemic toxicity.
Conclusions:
- MLT@ZIF-8 NPs represent a promising nanoplatform for delivering cytolytic peptides in cancer therapy.
- The developed nanoparticles offer a strategy to overcome the limitations of free melittin, enhancing its therapeutic index.
- Understanding the molecular mechanisms provides a basis for future clinical applications of melittin-based cancer treatments.
Related Concept Videos
Reaction Mechanisms
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
Self-Evaluation: Self-Enhancement and Self-Verification
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Mechanical Protein Functions

